483 Cedarburg Pharmaceuticals Apr 2013

483 Cedarburg Pharmaceuticals Apr 2013

Joel Hustedt FDA$119.00 - Available Now

FDA investigators audited the Cedarburg Pharmaceuticals - Grafton, WI, United States facility and issued inspectional observations (via FDA 483) on 04 Apr 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 04 Apr 2013
  • Location: Grafton, United States
  • FEI: 3001655239
Add To Cart